
|
|
Contact Us
Vivo Ventures 575 High Street, Suite 201 Palo Alto, CA 94301 (650) 688-0818 Phone (650) 688-0815 Fax info@vivoventures.com
Directions to Vivo Ventures
From SFO
|
News & Events
AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval Carbylan Announces $20 Million Series B Financing Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases BioForm Announces Pricing of Initial Public Offering Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence APT Pharmaceuticals Closes New $22 Million Funding Round Sagent Pharmaceuticals Inc. Completes $53M Series A Financing Acura Pharmaceuticals, Inc. secures financing to fund pivotal Phase III clinical trial for lead Aversion® technology product candidate Capnia names chairman, CEO Biodel Inc. Announces Completion of Public Offering Vivo Ventures Announces the Closing of Vivo Ventures Fund VI, a $275M Life Science Venture Fund TransOral Pharmaceuticals Raises $40 Million in Series D Financing Synapse BioMedical Completes Series C Private Equity Financing InteKrin Therapeutics Secures $23 M Venture Financing Biodel Inc. Raises $21 Million in Series B Financing Naryx Pharma Completes Series B2 Private Equity Financing
|